Brief: Shilpa Medicare Restrained From Manufacturing And Exporting Ruxolitinib
30/12/2025 08:33
Dec 30 (Reuters) - Shilpa Medicare Ltd SHME.NS: SHILPA MEDICARE LTD - RECEIVES INJUNCTION FROM DELHI HIGH COURT SHILPA MEDICARE LTD - RESTRAINED FROM MANUFACTURING AND EXPORTING RUXOLITINIB Source text: ID:nNSE7Ggr0N Further company coverage: SHME.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026